European Society of Gene & Cell Therapy

European Society of Gene & Cell Therapy

17 Oct 2017

European Society of Gene & Cell Therapy 2017

Join us at booth #3

Visit booth #3 to learn about the NEW Next-Generation IncuCyte® S3 Live-Cell Analysis System, the iQue® Screener PLUS and the latest trends and applications in real-time live-cell analysis.

We are proud to announce that Essen BioScience, makers of the IncuCyte® Live-Cell Analysis System, together with IntelliCyt, are now part of the Sartorius Group!

Sartorius, a global leader and supplier of biopharmaceutical and laboratory products and services, acquired these ground-breaking companies as a recent strategic expansion of the Sartorius portfolio to include highly innovative cell analysis platforms and products.

Novel analytical methods are crucial to enable scientific progress in the rapidly advancing areas of oncology, immuno-oncology, antibody discovery, neuroscience and stem cell research. Both the IncuCyte® and the IntelliCyt iQue® Screener PLUS systems provide specialized innovative instrumentation, software and reagents for live-cell analysis to accelerate discovery and development of new therapies and provide new insight into the mechanisms of disease at a speed, depth and scale not achievable with conventional cell analysis techniques.

LEARN MORE ABOUT ESGCT 2017

No file selected
0%
Stay up-to-date with what's happening at Essen BioScience

© 2019 Essen BioScience

Privacy Policy